Jessica Zablocki da Luz

Dr. Jessica Zablocki da Luz

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2020 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
TMThiago Neves Machado
Thiago Neves Machado
ABArandi Ginane Bezerra
Arandi Ginane Bezerra
CRCiro Alberto de Oliveira Ribeiro
Ciro Alberto de Oliveira Ribeiro
FNFrancisco Filipak Neto
Francisco Filipak Neto

14 March 2025 in Chemosphere
Verified
Journal Article
Closed access
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
VGVladimir Gorshkov
Vladimir Gorshkov
RMRenata Rank Miranda
Renata Rank Miranda
TSTugstênio Lima de Souza
Tugstênio Lima de Souza
LRLucas Rodrigues Ribeiro
Lucas Rodrigues Ribeiro
FNFrancisco Filipak Neto
Francisco Filipak Neto

1 December 2021 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
AGAndressa Glinski
Andressa Glinski
TSTugstênio Lima de Souza
Tugstênio Lima de Souza
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
AJArandi Ginane Bezerra Jr
Arandi Ginane Bezerra Jr
COCarolina Camargo de Oliveira
Carolina Camargo de Oliveira
FNFrancisco Filipak Neto
Francisco Filipak Neto

21 October 2025 in Journal of Applied Toxicology
Verified
Journal Article
Open access
CCCamila Confortin
Camila Confortin
HAHeloisa Amancio
Heloisa Amancio
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
Aliciane Almeida de Almeida RoqueAliciane Almeida de Almeida Roque
Aliciane Almeida de Almeida Roque
TSTugstênio Lima de Souza
Tugstênio Lima de Souza
FNFrancisco Filipak Neto
Francisco Filipak Neto
Human exposure to industrial chemical compounds is widespread and, although often beneficial, prolonged contact may contribute to disease development, including cancer. While many studies have shown organic pollutants (OP) are cytotoxic, few have explored how long‐term exposure alters cell phenotype. Therefore, the current study investigated whether exposure to the OP perfluorooctanoic acid (Pfoa: 0.01, 0.1, and 1 μM), bisphenol A (Bpa: 0.1 and 1 μM), methoxychlor (Mtx: 0.1 and 1 μM), and benzophenone‐1 (Bp1: 1 and 10 μM) modulates the phenotype of MCF7 human breast cancer cells and MCF10A normal breast epithelial cells. MCF7 cells were exposed to environmentally relevant concentrations of the OP for 24 h and 15 days. Cell viability, proliferation, colony formation, drug‐efflux activity, and gene expression were assessed. A modulation of MCF7 breast cancer cell phenotype was observed, with increased proliferation and colony formation (Pfoa, Bpa, Mtx, Bp‐1), particularly at 15‐day exposure and with expression of genes involved in cell survival, proliferation, differentiation, and chemoresistance (STAT3 and VEGFA [Bpa, Mtx, Bp‐1], BRCA1 [Bp1], ESR2 [Pfoa, Bpa], ABCG2 [Pfoa]). No effects on cell migration and drug‐efflux activity were observed. Likewise, an increase in cell proliferation also occurred for MCF10A nontumor cells (Bpa, Mtx, Bp‐1), but these effects were usually less pronounced than those observed in MCF7 cells. Pan‐cancer analysis revealed a negative correlation between the expression of STAT3, VEGFA, ESR2, and ABCG2 and breast cancer patient survival. These findings suggest that low‐concentration, prolonged exposure to OP may promote tumor progression and aggressiveness in breast cancer, potentially undermining therapeutic outcomes.

17 August 2020 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
LCLudiana Cardoso da Silva Cansian
Ludiana Cardoso da Silva Cansian
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
AJArandi Ginane Bezerra Jr
Arandi Ginane Bezerra Jr
TMThiago Machado
Thiago Machado
MSMichelle Thays Khun Santurio
Michelle Thays Khun Santurio
FNFrancisco Filipak Neto
Francisco Filipak Neto
Gold (AuNP) and silver (AgNP) nanoparticles have been incorporated into many therapeutic and diagnostic applications. However, previous studies revealed toxic properties as well as hormesis phenomenon of many nanoparticles in different biological models. To evaluate the effects of low concentrations of AuNP and AgNP on murine melanoma cells B16F1 and B16F10 and relate them with phenotype changes, cells were exposed for 24 and 48h. No cytotoxicity was observed for B16 cells through neutral red, MTT, trypan blue and crystal violet assays at concentrations from 0.01 to 10 ng mL−1. Likewise, the nanoparticles did not interfere with drug-efflux activity, cell migration, cell cycle and colony formation. Slight toxicity was observed for B16F10 exposed to 100 ng mL−1, with decreased number of viable and attached cells, indicating differential sensitivity of B16F1 and B16F10 cells to the nanoparticles. Furthermore, colony size dispersion decreased for both B16 cell sub-lines. Therefore, there is no evidence that the tested concentrations of AuNP and AgNP can render B16 cells more aggressive and malignant, which is important since both nanoparticles are already largely used in nanotechnological products. Considering studies that have showed hormesis effect of nanoparticles at low concentrations, which could protect cancer cells against chemotherapy, further investigation is advised.

12 December 2023 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
MMMicheli de Marchi
Micheli de Marchi
EMErick Laurent Moggio
Erick Laurent Moggio
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
PBPatricia Manuitt Brito
Patricia Manuitt Brito
SSSilvana Sandri
Silvana Sandri
CRCiro Alberto Oliveira Ribeiro
Ciro Alberto Oliveira Ribeiro